A detailed history of Rps Advisory Solutions LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Rps Advisory Solutions LLC holds 3,142 shares of ABBV stock, worth $743,271. This represents 0.32% of its overall portfolio holdings.

Number of Shares
3,142
Previous 3,065 2.51%
Holding current value
$743,271
Previous $642 Million 9.19%
% of portfolio
0.32%
Previous 0.45%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 06, 2025

BUY
$170.16 - $206.27 $13,102 - $15,882
77 Added 2.51%
3,142 $583 Million
Q1 2025

May 09, 2025

SELL
$169.2 - $216.66 $10,828 - $13,866
-64 Reduced 2.05%
3,065 $642 Million
Q4 2024

Feb 03, 2025

SELL
$164.99 - $203.87 $38,937 - $48,113
-236 Reduced 7.01%
3,129 $556 Million
Q3 2024

Oct 18, 2024

BUY
$163.84 - $199.33 $655 - $797
4 Added 0.12%
3,365 $664 Million
Q2 2024

Jul 25, 2024

BUY
$154.79 - $180.76 $520,249 - $607,534
3,361 New
3,361 $576 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $418B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Rps Advisory Solutions LLC Portfolio

Follow Rps Advisory Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rps Advisory Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rps Advisory Solutions LLC with notifications on news.